Literature DB >> 12719998

Pseudotumor cerebri associated with Sjögren's syndrome.

Dinu Stanescu1, Bahram Bodaghi, Du Le Thi Huong, Dan Milea, B Goulet-Salmon, Jean-Charles Piette, Phuc LeHoang.   

Abstract

PURPOSE: To report a case of papilledema and pseudotumor cerebri developed in association with Sjögren's syndrome.
METHODS: Case-report of a 38-year-old woman with history, imaging and histology confirming the diagnosis of both pseudotumor cerebri and Sjögren's syndrome who presented with bilateral decrease of vision.
RESULTS: Papilledema associated with pseudotumor cerebri was observed in both eyes. The patient's visual acuity improved transiently with the administration of intravenous steroids and cyclophosphamide; subsequently she needed a ventriculoperitoneal shunt.
CONCLUSION: Sjögren's syndrome should be considered in the different etiologies of pseudotumor cerebri. The major improvement with corticosteroids and ventriculoperitoneal shunt makes prompt diagnosis essential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719998     DOI: 10.1007/s00417-002-0620-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

Review 1.  Elevated intracranial pressure and pseudotumor cerebri.

Authors:  P W Brazis; A G Lee
Journal:  Curr Opin Ophthalmol       Date:  1998-12       Impact factor: 3.761

2.  Study of pseudotumor cerebri in vitamin A deficient rabbit.

Authors:  A el Ouahabi; A V Lorenzo; P M Black
Journal:  Eur J Pediatr Surg       Date:  1992-12       Impact factor: 2.191

Review 3.  [Bilateral optic neuropathy disclosing primary Gougerot-Sjögren syndrome].

Authors:  P Rapoport; H Merle; D Smadja; M Gerard; E Alliot
Journal:  J Fr Ophtalmol       Date:  1997       Impact factor: 0.818

4.  Raised intracranial pressure in chronic respiratory disease.

Authors:  B Brockmeier; H Burbach; M Runge; H Altenkirch
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

5.  Effects of weight loss on the course of idiopathic intracranial hypertension in women.

Authors:  M J Kupersmith; L Gamell; R Turbin; V Peck; P Spiegel; M Wall
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

6.  Letter: Pseudotumor cerebri and low vitamin-A intake.

Authors:  C Edmunds; M Behrens; L Lewis; R Lennon
Journal:  JAMA       Date:  1973-11-05       Impact factor: 56.272

Review 7.  Sjögren syndrome.

Authors:  K F Tabbara; C L Vera-Cristo
Journal:  Curr Opin Ophthalmol       Date:  2000-12       Impact factor: 3.761

8.  Association of xerophthalmia, flecked retina, and pseudotumor cerebri caused by hypovitaminosis A.

Authors:  G Panozzo; S Babighian; A Bonora
Journal:  Am J Ophthalmol       Date:  1998-05       Impact factor: 5.258

9.  Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease.

Authors:  G T Liu; M D Kay; D C Bienfang; N J Schatz
Journal:  Am J Ophthalmol       Date:  1994-03-15       Impact factor: 5.258

10.  Sjögren syndrome: central nervous system manifestations.

Authors:  G E Alexander; T T Provost; M B Stevens; E L Alexander
Journal:  Neurology       Date:  1981-11       Impact factor: 9.910

View more
  3 in total

1.  A rare initial neurological presentation of Sjogren's syndrome.

Authors:  Srikanteswara Praveen Kumar
Journal:  J Neurosci Rural Pract       Date:  2015-01

2.  The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: exploration of a shared pathophysiology.

Authors:  Mieke Hulens; Ricky Rasschaert; Greet Vansant; Ingeborg Stalmans; Frans Bruyninckx; Wim Dankaerts
Journal:  J Pain Res       Date:  2018-12-10       Impact factor: 3.133

3.  Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children, Associated With COVID-19.

Authors:  Alyssa Baccarella; Alexandra Linder; Robert Spencer; Alexander J Jonokuchi; Paul Benjamin King; Angel Maldonado-Soto; Alexis Boneparth; Benjamin S Hooe; Adam J Schweickert; Rebecca F Carlin; Francesca Kingery; Wendy S Vargas; Taylor B Sewell; Wendy G Silver
Journal:  Pediatr Neurol       Date:  2020-11-22       Impact factor: 3.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.